Phase II trial of combination chemotherapy consisting of S-1 and Oxaliplatin in patients with advanced or recurrent mucinous adenocarcinoma of the ovary
Not Applicable
- Conditions
- Mucinous adenocarcinoma of the ovary including metastatic ovarian cancer
- Registration Number
- JPRN-UMIN000001541
- Lead Sponsor
- Japan ovarian mucinous adenocarcinoma study group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients having fever over 38.0 2.Patients with infection or more than WBC:12,000/mm3 3.Patients with severe complications 4.Patients with double cancer 5.Patients with massive pleural effusion, ascites and pericardial fluid need to continuous drainage 6.Patients with severe paresthesia with functional disorder, or dysesthesia 7.Patients who cannot undergo treatment due to the past history of mental disorder or the central nerve disorder 8.Patients with brain metastasis 9.Patients with more than grade 3 diarrhea. More than grade 2 diarrhea in patients receiving colostomy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate
- Secondary Outcome Measures
Name Time Method The incidence of adverse event Progression free survival Overall survival